Jeffrey L. Roberson, MD

Original Research

Further Histological and Cellular Characterization of Hidradenitis Suppurativa in 11 Patients

12/03/2019

Jeffrey W. Shupp , MD;

Bonnie C. Carney , BS ;

Abdulnaser Alkhalil , PhD;

Lauren T. Moffatt , PhD;

Saira Nisar , MBBS, MS;

Jeffrey L. Roberson , MD;

Abdulnaser Alkhalil , PhD;

Jeffrey L. Roberson , MD;

Jeffrey L. Roberson , MD;

Bonnie C. Carney , BS ;

Jeffrey W. Shupp , MD;

Jeffrey W. Shupp , MD;

Lauren T. Moffatt , PhD;

Lauren T. Moffatt , PhD;

Saira Nisar , MBBS, MS;

Saira Nisar , MBBS, MS;

Jeffrey L. Roberson , MD;

Jeffrey W. Shupp , MD;

Abdulnaser Alkhalil , PhD;

Lauren T. Moffatt , PhD;

Bonnie C. Carney , BS ;

Saira Nisar , MBBS, MS;

Abdulnaser Alkhalil , PhD;

Jeffrey L. Roberson , MD;

Bonnie C. Carney , BS ;

Jeffrey W. Shupp , MD;

Abdulnaser Alkhalil , PhD;

Lauren T. Moffatt , PhD;

Bonnie C. Carney , BS ;

Saira Nisar , MBBS, MS;

Abdulnaser Alkhalil , PhD;

Jeffrey L. Roberson , MD;

Jeffrey L. Roberson , MD;

Bonnie C. Carney , BS ;

Jeffrey W. Shupp , MD;

Jeffrey W. Shupp , MD;

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that classically presents as recurrent painful, exudative lesions, most often found in intertriginous areas with a high density of apocrine glands

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that classically presents as recurrent painful, exudative lesions, most often found in intertriginous areas with a high density of apocrine glands

Hidradenitis suppurativa (HS) is...

12/03/2019

ePlasty

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

April 30 ⁠–⁠ May 5

WoundCon

May 1 ⁠–⁠ May 3

May 19 ⁠–⁠ May 21

See Full Calendar